Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

tRNA Activation02:26

tRNA Activation

22.9K
Aminoacyl-tRNA synthetases are present in both eukaryotes and bacteria. Though eukaryotes have 20 different aminoacyl-tRNA synthetases to couple to 20 amino acids, many bacteria do not have genes for all of these aminoacyl-tRNA synthetases. Despite this, they still use all 20 amino acids to synthesize their proteins. For instance, some bacteria do not have the gene encoding the enzyme that couples glutamine with its partner tRNA. In these organisms, one enzyme adds glutamic acid to all of the...
22.9K
Eukaryotic Transcription Activators02:42

Eukaryotic Transcription Activators

12.8K
Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
12.8K
Acid–Base Equilibria: Activity-Based Definition of pH01:10

Acid–Base Equilibria: Activity-Based Definition of pH

1.3K
For an ideal solution, the pH is defined as the negative logarithm of the hydrogen ion concentration. For a non-ideal solution, an accurate measurement of the pH must consider the negative logarithm of the hydrogen ion activity rather than concentration. In such a solution, the pH can be more accurately defined as the negative logarithm of a product of the hydrogen ion concentration and its activity coefficient.
In solutions of very low ionic strength—for example, pure water—the...
1.3K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

8.6K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.6K
Activation Energy01:26

Activation Energy

86.6K
Activation energy is the minimum amount of energy necessary for a chemical reaction to move forward. The higher the activation energy, the slower the rate of the reaction. However, adding heat to the reaction will increase the rate, since it causes molecules to move faster and increase the likelihood that molecules will collide. The collision and breaking of bonds represents the uphill phase of a reaction and generates the transition state. The transition state is an unstable high-energy state...
86.6K
Prokaryotic Transcriptional Activators and Repressors01:58

Prokaryotic Transcriptional Activators and Repressors

25.5K
The organization of prokaryotic genes in their genome is notably different from that of eukaryotes. Prokaryotic genes are organized, such that the genes for proteins involved in the same biochemical process or function are located together in groups. This group of genes, along with their regulatory elements, are collectively known as an operon. The functional genes in an operon are transcribed together to give a single strand of mRNA known as polycistronic mRNA.
Transcription of prokaryotic...
25.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparable myopia control efficacy of highly aspherical lenslets and diffusion optics technology spectacle lenses: a one-year real-world cohort study.

BMC ophthalmology·2026
Same author

Author Correction: Metagenomic fingerprints in bronchoalveolar lavage differentiate pulmonary diseases.

NPJ digital medicine·2026
Same author

Transcriptome-guided development of a fibrosis-reversal compound reduces skin scarring and allows regeneration via mitochondrial uncoupling.

Cell reports. Medicine·2026
Same author

Predicted brain-regional gene expression patterns in individuals living with Alzheimer's disease.

Neurobiology of aging·2026
Same author

Toward Sustainable Lithium Recovery: A Universal Hydrothermal Approach for Lithium Extraction.

ACS applied materials & interfaces·2026
Same author

Free water changes and their correlations with multimodal biomarkers in frontotemporal dementia.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Related Experiment Video

Updated: Feb 4, 2026

A Colorimetric Assay of Citrate Synthase Activity in Drosophila Melanogaster
04:30

A Colorimetric Assay of Citrate Synthase Activity in Drosophila Melanogaster

Published on: January 16, 2020

10.7K

2-Hydroxy-oleic acid does not activate sphingomyelin synthase activity.

Bin Lou1, Qi Liu2, Jiahui Hou2

  • 1From the School of Pharmacy, Fudan University, Shanghai 201203, China,.

The Journal of Biological Chemistry
|October 12, 2018
PubMed
Summary

2-Hydroxy-oleic acid (2OHOA) does not activate SMS enzymes as previously thought. Its anticancer effects may stem from reducing phosphatidylcholine levels, impacting cell membranes.

Keywords:
2-hydroxy-oleic acid (2OHOA)anti-cancer drugcancerlipidlipid metabolismlysophosphatidylcholine acyltransferase (LPCAT)phosphatidylcholinephospholipidsphingolipidsphingomyelinsphingomyelin synthase (SMS)

More Related Videos

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
10:42

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

9.9K
Quantitative and Qualitative Method for Sphingomyelin by LC-MS Using Two Stable Isotopically Labeled Sphingomyelin Species
08:53

Quantitative and Qualitative Method for Sphingomyelin by LC-MS Using Two Stable Isotopically Labeled Sphingomyelin Species

Published on: May 7, 2018

10.3K

Related Experiment Videos

Last Updated: Feb 4, 2026

A Colorimetric Assay of Citrate Synthase Activity in Drosophila Melanogaster
04:30

A Colorimetric Assay of Citrate Synthase Activity in Drosophila Melanogaster

Published on: January 16, 2020

10.7K
A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
10:42

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

9.9K
Quantitative and Qualitative Method for Sphingomyelin by LC-MS Using Two Stable Isotopically Labeled Sphingomyelin Species
08:53

Quantitative and Qualitative Method for Sphingomyelin by LC-MS Using Two Stable Isotopically Labeled Sphingomyelin Species

Published on: May 7, 2018

10.3K

Area of Science:

  • Biochemistry
  • Cancer Biology
  • Pharmacology

Background:

  • 2-Hydroxy-oleic acid (2OHOA) is recognized for its anticancer properties, inducing apoptosis and cell cycle arrest.
  • Prior research suggested its mechanism involved sphingomyelin synthase (SMS) activation in cancer cells.

Purpose of the Study:

  • To investigate the proposed role of SMS activation in 2OHOA's anticancer effects.
  • To examine the impact of 2OHOA on sphingomyelin and phosphatidylcholine metabolism in cancer cells and in vivo.

Main Methods:

  • Treatment of A549 and U118 cancer cells with 2OHOA.
  • Measurement of SMS activity, sphingomyelin, and phosphatidylcholine levels.
  • Inhibition assays with recombinant SMS1 (rSMS1) and SMS2 (rSMS2).
  • In vivo studies involving oral administration of 2OHOA to C57BL/6J mice, assessing SMS activity, sphingomyelin, and lysophosphatidylcholine acyltransferase (LPCAT) activity.

Main Results:

  • 2OHOA did not activate SMS or increase sphingomyelin in treated cells or mouse tissues.
  • A significant reduction in phosphatidylcholine was observed in cancer cells treated with 2OHOA.
  • 2OHOA demonstrated dose-dependent inhibition of rSMS1 and rSMS2.
  • In vivo, 2OHOA did not affect liver/intestinal SMS activity or plasma sphingomyelin but inhibited LPCAT activity.

Conclusions:

  • 2OHOA is not an SMS activator; its anticancer effects are likely linked to phosphatidylcholine metabolism disruption.
  • The reduction in phosphatidylcholine may alter cell membrane properties, contributing to observed anticancer activity.
  • This finding reframes the understanding of 2OHOA's mechanism of action in cancer therapy.